Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Patients considering combination approaches should understand that this represents an unproven strategy that increases cost and injection burden without documented benefit
V., Libiad, M
The fate of new fosfamides in phase iii studies in advanced soft tissue sarcoma
Regular audits of blinding procedures were conducted to ensure compliance
Diabetes 60 , 13991413 (2011)
US$ 23.86
US$ 25.73
US$ 21.38
US$ 23.56
US$ 29.94
US$ 21.61
US$ 29.63
